Targeting Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) for Lipid-Lowering

LI Yuan, LI Wenlan, GUO Shoudong

Chinese Pharmaceutical Journal ›› 2023, Vol. 58 ›› Issue (24) : 2228-2234.

PDF(1620 KB)
PDF(1620 KB)
Chinese Pharmaceutical Journal ›› 2023, Vol. 58 ›› Issue (24) : 2228-2234. DOI: 10.11669/cpj.2023.24.006

Targeting Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) for Lipid-Lowering

  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2023, 58(24): 2228-2234 https://doi.org/10.11669/cpj.2023.24.006

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1620 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉